TAP
GSK icon

Tounjian Advisory Partners’s GSK GSK Stock Holding History

Tounjian Advisory Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.47K Buy
+104
New +$5.5K ﹤0.01% 437

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Tounjian Advisory Partners's GSK Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in GSK (GSK) in Q2 2026: 104 shares worth $5.47K. The stake represents ﹤0.01% of the portfolio and ranks #437 among its holdings.

683 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Tounjian Advisory Partners held 104 shares of GSK worth $5.47K as of Q2 2026.
  • GSK was a new Tounjian Advisory Partners position in Q2 2026.
  • GSK made up ﹤0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #437 holding.
  • 683 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.